- Home
- AMRN vs ACV Comparison
AMRN vs ACV Comparison
Compare AMRN & ACV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AMRN
- ACV
- Stock Information
- Founded
- AMRN 1989
- ACV 2015
- Country
- AMRN Ireland
- ACV United States
- Employees
- AMRN N/A
- ACV N/A
- Industry
- AMRN Biotechnology: Pharmaceutical Preparations
- ACV Finance/Investors Services
- Sector
- AMRN Health Care
- ACV Finance
- Exchange
- AMRN Nasdaq
- ACV Nasdaq
- Market Cap
- AMRN 216.0M
- ACV 234.1M
- IPO Year
- AMRN 1993
- ACV N/A
- Fundamental
- Price
- AMRN $14.52
- ACV $22.65
- Analyst Decision
- AMRN Strong Sell
- ACV
- Analyst Count
- AMRN 1
- ACV 0
- Target Price
- AMRN $12.00
- ACV N/A
- AVG Volume (30 Days)
- AMRN 88.3K
- ACV 38.8K
- Earning Date
- AMRN 07-30-2025
- ACV 01-01-0001
- Dividend Yield
- AMRN N/A
- ACV 9.20%
- EPS Growth
- AMRN N/A
- ACV N/A
- EPS
- AMRN N/A
- ACV N/A
- Revenue
- AMRN $219,361,000.00
- ACV N/A
- Revenue This Year
- AMRN N/A
- ACV N/A
- Revenue Next Year
- AMRN N/A
- ACV N/A
- P/E Ratio
- AMRN N/A
- ACV N/A
- Revenue Growth
- AMRN N/A
- ACV N/A
- 52 Week Low
- AMRN $7.08
- ACV $16.82
- 52 Week High
- AMRN $17.49
- ACV $23.74
- Technical
- Relative Strength Index (RSI)
- AMRN 42.13
- ACV 55.40
- Support Level
- AMRN $14.45
- ACV $22.41
- Resistance Level
- AMRN $15.61
- ACV $22.94
- Average True Range (ATR)
- AMRN 0.60
- ACV 0.25
- MACD
- AMRN -0.30
- ACV -0.04
- Stochastic Oscillator
- AMRN 5.88
- ACV 53.23
About AMRN Amarin Corporation plc
Amarin Corp PLC is a biopharmaceutical company. It is focused on the commercialization and development of therapeutics to improve cardiovascular, or CV, health and reduce CV risk. Its commercialized product includes Vascepa.
About ACV Virtus Diversified Income & Convertible Fund of Beneficial Interest
Virtus AllianzGI Diversified Income & Convertible Fund is a diversified, limited-term, closed-end management investment company. The fund's investment objective is to provide total return through a combination of current income and capital appreciation while seeking to provide downside protection against capital loss. It invests in a diversified portfolio of convertible securities, income-producing equity securities, and income-producing debt and other instruments of varying maturities, of which a majority of the managed assets are invested in convertibles.